The 2026 BCAN Continuity Grant supports U.S. investigators whose bladder cancer research lost federal funding or narrowly missed NIH funding, helping scientifically reviewed projects continue.
The Bladder Cancer Research Innovation Award supports investigators pursuing novel, high-risk research on bladder cancer or upper tract urothelial carcinoma to overcome key barriers and advance understanding.
Young Investigator Awards from the Bladder Cancer Advocacy Network support early-career cancer researchers studying bladder and upper tract urothelial cancer to improve understanding, treatment, and patient experience.
The 2026 AAAAI Bridge Funding Award for Research Continuity supports investigators with essential research costs during temporary funding gaps to preserve research momentum and retain critical personnel.
Advanced Clinical Research Award supports independent mid-career physicians pursuing original breast cancer clinical or human-subjects translational research to address patient needs and potential benefit.
Supports innovative research to discover and investigate new targets or biomarkers for kidney cancer, encouraging basic, translational, and clinical science that could lead to new treatments.